Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Calcineurin Inhibitors/adverse effects"'
Autor:
Carle Paul, Ulrich Wahn, Thomas Werfel, Julien Lambert, Christian Vestergaard, Matthias Augustin, Antonio Torrelo, Thomas A. Luger, Carlo Pincelli
Publikováno v:
Luger, T, Augustin, M, Lambert, J, Paul, C, Pincelli, C, Torrelo, A, Vestergaard, C, Wahn, U & Werfel, T 2021, ' Unmet medical needs in the treatment of atopic dermatitis in infants : An Expert consensus on safety and efficacy of pimecrolimus ', Pediatric Allergy and Immunology, vol. 32, no. 3, pp. 414-424 . https://doi.org/10.1111/pai.13422
Pediatric allergy and immunology
Pediatric allergy and immunology
Atopic dermatitis (AD) is a common skin disease during infancy, which imposes a considerable burden on patients, their families, and the society, requiring effective treatment options that result in rapid and sustained symptom relief. Additionally, e
Autor:
Helle C. Thiesson, Line Aas Mortensen, Claus Bistrup, Birgitte Tougaard, Anne Sophie Lind Fischer, Martin Egfjord
Publikováno v:
Mortensen, L A, Thiesson, H C, Tougaard, B, Egfjord, M, Fischer, A S L & Bistrup, C 2018, ' The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity : A multicenter randomized, double-blind, clinical trial (the SPIREN trial) ', BMC Nephrology, vol. 19, no. 1, 105 . https://doi.org/10.1186/s12882-018-0885-6
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
BMC Nephrology
Mortensen, L A, Thiesson, H C, Tougaard, B, Egfjord, M, Fischer, A S L & Bistrup, C 2018, ' The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity : a multicenter randomized, double-blind, clinical trial (the SPIREN trial) ', BMC Nephrology, vol. 19, no. 1, 105, pp. 1-7 . https://doi.org/10.1186/s12882-018-0885-6
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
BMC Nephrology
Mortensen, L A, Thiesson, H C, Tougaard, B, Egfjord, M, Fischer, A S L & Bistrup, C 2018, ' The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity : a multicenter randomized, double-blind, clinical trial (the SPIREN trial) ', BMC Nephrology, vol. 19, no. 1, 105, pp. 1-7 . https://doi.org/10.1186/s12882-018-0885-6
BACKGROUND: Calcineurin inhibitor induced nephrotoxicity contributes to late allograft failure in kidney transplant patients. Evidence points towards aldosterone to play a role in the development of fibrosis in multiple organs. Animal studies have in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d2f716fbb9fb36d1fd10f08b4e0596
https://findresearcher.sdu.dk:8443/ws/files/141325192/The_effect_of_spironolactone_on_calcineurin_inhibitor_induced_nephrotoxicity.pdf
https://findresearcher.sdu.dk:8443/ws/files/141325192/The_effect_of_spironolactone_on_calcineurin_inhibitor_induced_nephrotoxicity.pdf